Collagen, as the predominant structural protein in vertebrates, represents a promising biomimetic material for scaffold development. Fibre-based scaffolds produced through textile technologies enable precise modulation of structural characteristics to closely mimic the extracellular matrix architecture using wet-spun collagen fibres. However, this in vitro fibre formation lacks natural crosslinking, resulting in collagen fibres with compromised mechanical strength, enzymatic resistance, and thermal stability compared to their native counterparts, thus restricting their biomedical applicability. Post-fabrication crosslinking is therefore imperative to enhance the durability and functional performance of collagen fibre-based scaffolds. Although traditional crosslinkers like glutaraldehyde effectively improve mechanical strength and stability, their clinical utility is hindered by cytotoxicity and associated adverse biological responses. Alternative synthetic crosslinking agents, such as hexamethylene diisocyanate, 1-Ethyl-3-(3’-dimethyl amino propyl) carbodiimide, and 1,4-Butanediol diglycidyl ether, have demonstrated superior cytocompatibility while effectively improving collagen fibre properties. Nonetheless, synthetic compounds may induce more pronounced foreign body reaction than natural agents, necessitating further investigation into their cytocompatibility across varying concentrations. In contrast, plant-based crosslinking offers a promising, cytocompatible alternative, significantly enhancing the thermal and mechanical stability of collagen fibres, provided that potential fibre discolouration is acceptable for intended biomedical applications.

Liquid crystal elastomers (LCE) are a promising material to achieve reversible actuation while being able to perform work, showing great potential as artificial muscles in soft robotics and medical technology. Here, a wet spinning process to prepare liquid crystal elastomer fibers (LCEF) with reversible actuation capability is presented. Furthermore, we demonstrate the ability to process side-chain liquid crystal (LC) 4-Methoxyphenyl 4-(3-butenyloxy)benzoate (MBB) into a fiber, enlarging the material variance available in this field. The wet spinning process is presented and discussed in terms of spinning parameters and their influence on fiber properties, especially LC orientation. Moderate draw ratios of up to 2.3 enable highly oriented mesogens (f = 0.64), enabling the contractile behavior. The generated MBB-based LCEF show low activation temperature (54.52 °C), temperature-dependent mechanical properties, reversible contraction behavior while lifting up to 140 times their own weight and are able to perform work of up to 3.857 J kg⁻¹. Actuation properties are compared with human skeletal muscle, and possible strategies of further enhancing the LCEF performance are discussed. The generated data show promising features of the LCEF for use as artificial muscle fibers in medical applications, e.g., prosthetics and artificial cardiac tissue.